IE 11 is not supported. For an optimal experience visit our site on another browser.

Momenta Pharmaceuticals to Present at the UBS Global Life Sciences Conference

/ Source: GlobeNewswire

CAMBRIDGE, Mass., Sept. 17, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Craig Wheeler, President and Chief Executive Officer, will deliver a corporate presentation at the UBS Global Life Sciences Conference on Monday, September 20th at 8:30 am EDT. The conference will be held at the Grand Hyatt New York, New York City.

A live audio webcast of the presentation will be available on the "Investors" section of the Company's website located at . A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available through December 19th, 2011.

About Momenta

Momenta Pharmaceuticals is a biotechnology company, headquartered in Cambridge, MA, specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. 

To receive additional information about Momenta, please visit the website at , which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

CONTACT: Momenta Pharmaceuticals, Inc. Beverly Holley, Director, Investor Relations 617-395-5189